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Abstract  
 
 
AIMS: The secondary dystroglycanopathies represent a heterogeneous group of congenital muscular 
dystrophies characterised by the defective glycosylation of alpha dystroglycan.  These disorders are 
associated with mutations in at least 17 genes, including Fukutin-related protein (FKRP). At the severe 
end of the clinical spectrum there is substantial brain involvement, and cobblestone lissencephaly is 
highly suggestive of these disorders. The precise pathogenesis of this phenotype has however, 
remained unclear with most attention focused on the disruption to the radial glial scaffold.  Here we 
set out to investigate whether lesions are apparent prior to the differentiation of the radial glia. 
 
METHODS: A detailed investigation of the structural brain defects from embryonic day 10.5 (E10.5) up 
until the time of birth (P0) was undertaken in the Fkrp deficient mice (FKRPKD).   Reelin, and 
downstream PI3K/Akt signalling pathways were analysed using Western blot. 
 
RESULTS: We show that early basement membrane defects and neuroglial ectopia precede radial glial 
cell differentiation.  Furthermore we identify mislocalisation of Cajal-Retzius cells which nonetheless 
is not associated with any apparent disruption to the reelin, and downstream PI3K/Akt signalling 
pathways. 
 
CONCLUSIONS: These observations identify Cajal Retzius cell mislocalisation as an early event during 
the development of cortical defects thereby identifying an earlier onset and more complex 
pathogenesis than originally reported for the secondary dystroglycanopathies.  Overall this study 
provides new insight into central nervous system involvement in this group of diseases. 
Introduction  
 
 
Type II lissencephaly (also referred to as cobblestone lissencephaly) is a type of neuronal migration 
disorder highly suggestive of a group of severe congenital muscular dystrophies, characterised by 
brain, eye and muscle defects.  These disorders include Walker-Warburg syndrome (WWS) and 
Muscle-Eye-Brain (MEB) disease, both of which display a range of substantial structural brain 
abnormalities associated with defects in neuronal migration [1].  In addition to type II lissencephaly, 
WWS and MEB show cortical and cerebellar dysplasia, polymicrogyria and hydrocephalus, with 
evidence of dysmyelination on MRI [2, 3]. Many of these patients characteristically show a marked 
reduction in the glycosylation of alpha dystroglycan - an extracellular matrix receptor which is a key 
component of the dystrophin-associated glycoprotein complex [4]. These are now collectively referred 
to as secondary dystroglycanopathies since they carry mutations in genes involved in the processing 
of alpha dystroglycan rather than in the gene encoding for dystroglycan itself. 
 
Alpha dystroglycan undergoes extensive O-mannosylation of its central mucin-rich domain, and it is 
these glycan chains that mediate binding to extracellular matrix proteins such as laminin [4], agrin [5- 
7],   perlecan [8], and neurexin, effectively forming a link between the actin cytoskeleton and the 
extracellular matrix [9].  Altered binding to the extracellular matrix brought about by a reduction in 
the glycosylation of alpha dystroglycan is considered central to the disease process in the 
dystroglycanopathies and to date, mutations in 17 putative or determined glycosyltransferase genes 
have been associated with this group of diseases. These include POMT1 [10], POMT2 [11], POMGNT1 
[5], LARGE [12], FKTN [13], FKRP [14], ISPD [15, 16], DPM1 [17], DPM2 [18], DPM3 [19], POMK [20], 
GMPPB [21], B3GALNT2 [22], GTDC2 [23], TMEM5 [24], B3GNT1 [25, 26] and DOLK [27, 28]. 
 
Fukutin-related protein (FKRP) is a putative glycosyltransferase, and mutations in FKRP produce a 
range of clinical phenotypes from WWS and MEB through to the late-onset limb girdle muscular 
dystrophy 2I (LGMD2I). In order to investigate the pathogenesis of the dystroglycanopathies further, 
we previously generated a mouse model of dystroglycanopathy which has a deficiency in fukutin- 
 related protein (FKRPKD). This mouse recapitulates some of the features of MEB; displaying a profound 
reduction in the glycosylation of alpha dystroglycan at the pial basement membrane, associated with 
basement membrane defects and a neuronal migration disorder [29, 30]. In the dystroglycanopathies, 
this brain phenotype has been attributed to the inability of the radial glial end feet to maintain 
integrity of the pial basement membrane during the period of rapid cortical expansion; a process 
considered central to the neuronal migration defect in these disorders [31, 32]. 
 
However, there is now a substantial body of work which suggests that the meninges, traditionally seen 
as a protective layer covering the brain, play a key role in the production of basement membrane 
components, retinoic acid and chemotactic factors which are essential for normal corticogenesis [33- 
36]. Moreover, we have previously identified leptomeningeal disruption in newborn FKRPKD mice [37] 
potentially implicating the meninges in the pathogenesis of the brain defects associated with the 
dystroglycanopathies. In order to further investigate this we have now undertaken a detailed study of 
FKRPKD mice from E10.5 until P0. These investigations clearly show that basement membrane lesions 
and neuroglial heterotopia occur prior to radial glial disruption. There is a variation in the time of onset 
of these lesions, which could account for the range of severity observed at later stages, but lesions 
were identifiable in all embryos by E11.5. We further show that these defects occur around the time 
of Cajal-Retzius cell migration but are not associated with changes in the reelin and downstream 
PI3K/Akt signalling pathways. 
 
Materials and methods 
 
 
Animal models 
 
 
All animal experiments were carried out under license from the Home Office (UK) in accordance with 
The Animals (Scientific Procedures) Act 1986 and were approved by the Royal Veterinary College 
ethics and welfare committee. 
 The FKRP-NeoTyr307Asn (FKRPKD) has a neomycin selection cassette in intron 2 and a missense mutation 
in exon 3. The missense mutation (Tyr307Asn) has previously been shown to result in no discernable 
phenotype however, the presence of the neomycin selection cassette results in an 80% reduction in 
FKRP transcript levels [29]. This mouse was crossed with the GLASTcreERT2, to produce a mouse model 
with a knock down in FKRP with the potential to restore FKRP expression in response to tamoxifen 
administration. 
 
Embryos 
 
The morning of identification of the copulatory plug was taken to be E0.5.  On the relevant day of 
gestation, the dam was euthanized by atlanto-occipital dislocation. The embryos were dissected out 
of the uterus, euthanized and fixed in ice cold Bouin’s solution (Sigma), and transferred to 70% ethanol 
prior to processing.   Prior to fixation, yolk sac or tail samples were collected and retained for 
genotyping. 
 
Neonates 
 
Mice were collected at P0 and killed by atlanto-occipital dislocation.  The heads were removed and 
fixed in Bouin’s solution (Sigma). The tails were collected for genotyping. 
 
Histology 
 
 
Following fixation, neonates and embryos were trimmed, processed and embedded in paraffin wax. 
Samples were serial sectioned at 5µm, with sections collected onto charged slides (Superfrost Plus, 
VWR, UK). Haematoxylin and eosin staining (H&E) was carried out using standard protocols. 
 
Blinded semi-quantitative ranking of brain lesions was undertaken in embryos at each gestational time 
point, scoring lesion severity from zero (not present), through to 4 (marked). 
 
Immunohistochemistry 
 
 
Sections were deparaffinised and rehydrated. Primary antibodies used in the study were as follows: 
 
rabbit anti-brain lipid binding protein 1:300 (Millipore), mouse anti-reelin 1:1000 (clone G10, Abcam, 
 UK), rabbit anti-pan laminin 1:100 (Sigma, UK), anti-beta dystroglycan 1:150 (clone 43DAG1/8D5, 
Abcam, UK) and anti-alpha dystroglycan 1:300 (IIH6, Millipore, UK). Primary antibodies were diluted 
in phosphate buffered saline containing 0.05% tween 20 (Sigma) and incubated on sections for 1 hour 
at room temperature. Visualisation of the primary antibody was performed using the Envision system 
(DAKO). Sections were viewed using a DM4000B upright microscope (Leica, Germany) interfaced with 
Leica DC500 colour camera. Figures were compiled using Photoshop CS5 (Adobe, U.S.A.). 
 
The number of Cajal-Retzius (CR) cells were counted in the rostral cortex, at the level of the corpus 
callosum. To ensure consistency, levels were matched using appropriate anatomical landmarks. The 
number of CR cells in the cortex were counted in each section.  For each mouse, three serial reelin- 
stained sections (5µm apart) were counted and the mean number of CR cells per animal was 
calculated. Values were compared using a one way ANOVA with Dunnett’s multiple comparisons. 
Western blot 
 
 
Whole brains were collected from E15.5  FKRPKD mice and lysed in (RIPA) buffer consisting of 50mM 
Tris-HCl pH 7.5, 1mM EDTA, 1% Triton X-100, 150mM NaCl, 1%SDS, plus a cocktail of protease 
inhibitors (cOmplete, ULTRA Mini EDTA free Roche) and phosphatase inhibitors (PhosStop, Roche). 
Protein concentration was measured using the BCA Protein Assay Kit (Thermo Scientific Pierce). 
Lysates were reduced and denatured and run on pre-cast polyacrylamide gels (Life Technologies), 
before transfer to PVDF membrane. Membranes were stained with antibodies to Akt (Cell Signalling, 
UK), PhosphoAkt (Cell Signalling, UK); Dab1 (Millipore, UK) and Lis1 (AbCam UK) and beta dystroglycan 
(Abcam, UK). Secondary horse radish peroxidase-conjugated goat anti-rabbit IgG and goat anti-mouse 
IgG antibodies (Jackson) were used to detect primary antibody binding, and staining was visualised 
with Pierce ECL western blotting substrate kit (Thermoscientific, UK). Membranes were imaged using 
the ChemiDoc MP system (BioRad, UK).  Density analysis was carried out with Image Lab software 
(BioRad). 
 
Genotyping 
 Genotype was confirmed by PCR. For FKRPKD mice, primers were as follows FKRP forward - 
GTTGTGCTTAAACCACCTTC; FKRP neo forward - GGTGGGATTAGATAAATGCC; FKRP reverse - 
CTAGGAGGTTGAGGATGATGG. 
 
 
 
 
Results 
 
 
Defects in the basement membrane and disorganisation of neuronal precursors are present 
prior to rapid cortical expansion 
Previous work in Pomgnt1-/-, Pomt2f/f;Emx1-Cre+ and Nestin cre-DG null embryos has suggested that the 
brain phenotype in the dystroglycanopathies is the result of a failure of radial glial cells to stabilise the 
basement membrane during a period of rapid cortical expansion [32, 38]. In order to further evaluate 
this we harvested brains from wild type and FKRPKD  embryos, at E10.5 and E11.5 (neuroepithelial 
stage), E12.5 (preplate stage) and E15.5 (middle of cortical expansion) to determine the point of onset 
of the neuropathologic phenotype. 
 
Disruption to the preplate is identified in FKRPKD mice early in brain development 
 
A subtle brain phenotype, characterised by multifocal disorganisation of the pre-plate was identifiable 
in haematoxylin and eosin (H&E) sections in 60% of FKRPKD  embryos at E10.5 and 100% by E15.5. 
Figure 1 shows a semi-quantitative assessment of lesion severity from E10.5 to E15.5. Lesions were 
categorised as follows:- 0 = normal, 1 = focal defects in the pial basement membrane, with herniation 
of cells through the defects, 2 = multifocal defects in the PBM, herniation of cells through defects, 3 = 
moderate disorganisation of the developing cortex, limited or multifocal organisation of the cortical 
plate, 4 = significant disruption to the developing cortex, no differentiation of the areas of 
organisation, 5 = complete disorganisation of the developing cortex, no normal structures apparent. 
 
These lesions most commonly occurred in the striatum of the lateral ganglionic eminence where at 
 
E10.5 in a proportion of embryos, irregularities at the interface between the LGE and mesenchyme 
 were observed (Figure 2).  Immunolabelling of the IIH6 epitope of glycosylated alpha dystroglycan at 
E10.5 reveals there is strong, diffuse staining of the wild type neuroepithelium at this time point 
(Figure 2C). However, despite only a proportion of embryos exhibiting a morphologically obvious 
lesion at this time point, hypoglycosylation of alpha dystroglycan, demonstrated by an absence of IIH6 
immunolabelling, was identified in all of the FKRPKD embryos examined (Figure 2D). In addition, the 
neuroepithelial basement membrane, immunopositive for laminin, which was clearly identifiable in 
wild type embryos at E10.5, was not apparent in FKRPKD embryos (Figure 2E,F). 
 
By E11.5 multifocal disruptions of the neuroepithelium and the clustering of ectopic cells within the 
surrounding mesenchyme were observed in the developing rhinencephalon, basal ganglia, thalamus 
and hippocampal formation in H&E stained sections from all FKRPKD embryos (Figure 1, Figure 2G,H). 
 
Preplate splitting is disturbed in FKRPKD embryos 
 
Detailed histological examination of embryos at E12.5 (Figure 3A-F) revealed multifocal disruption to 
the basement membrane, associated with disorganisation of the preplate and failure of the preplate 
to split.  These lesions were identified in all FKRPKD embryos at this time point (Figure 1).  Neurons 
were observed herniating through the basement membrane defects, often encompassing 
subarachnoid vessels, imparting a verrucous appearance at the cortical surface. These lesions were 
present in multiple locations in the developing brain, including the striatum of the lateral ganglionic 
eminence, the thalamus and hippocampal formation, but also in the anterior neocortex. Many of the 
locations correlated with sites at which lesions were obvious at P0. However, some affected areas did 
not demonstrate obvious neuropathological lesions at P0 (such as the thalamus). 
 
Defects in the pial basement membrane and the glia limitans correlate with both the degree of 
dyslamination and an absence of glycosylated alpha dystroglycan 
Pan  laminin  immunolabelling  showed  continuous  staining  of  the  pial  and  vascular  basement 
 
membranes in wild type embryos at E12.5. In FKRPKD embryos however, there was an extensive 
disruption of the pial basement membrane (Figure 4A-D). Whilst the vessels were mislocalised (and, 
 multifocally, almost completely encompassed by ectopic neurons), the vascular basement membranes 
themselves appeared intact. Immunolabelling for glycosylated alpha dystroglycan (IIH6) was evident 
both at the basement membrane, and in cellular processes within the ventral thalamus and the 
cortical hem of wild type embryos. Examination of coronal sections from FKRPKD embryos at this time 
point confirmed the absence of glycosylated alpha dystroglycan (Figure 4E,F). Beta dystroglycan was 
however, apparent in both wild type and mutant embryos characterised by granular immunopositive 
staining of cell bodies in the ventricular zone, which multifocally extended along cell processes. 
Labelling was particularly prominent in the developing thalamus, at the ganglionic eminences, and 
ventrally (Figure 5A,B). In addition to this, in wild type embryos, there was continuous laminar staining 
at the pial basement membrane whereas in the FKRPKD  embryos, beta dystroglycan staining at the 
basement membrane was fragmented. The vascular basement membranes were highlighted in both 
wild type controls and FKRPKD embryos. 
 
Since the onset of brain lipid binding protein (BLBP) expression coincides with the differentiation of 
neuroepithelial cells into radial glial cells, this marker was used to confirm that this phenotype 
preceded the formation of the radial glial scaffold.  Indeed at E12.5, both the FKRPKD and wild type 
exhibited similar patterns of BLBP staining, with foci of immunopositive cells at the medial ganglionic 
eminences, in the pallium (dorsal to the cortical hem) and in lateral aspects of the developing 
thalamus, but not at the glia limitans (Figure 5E-H). Overall these observations show that basement 
membrane defects in FKRPKD mice are first evident very early in development, prior to splitting of the 
preplate and the formation of the radial glial scaffold, the end feet of which have previously been 
attributed with a role in stabilising the basement membrane during periods of rapid cortical expansion 
[32]. 
 
Degenerative lesions, and fusion of the interhemispheric fissure, occur late in brain development 
Examination of serial-sectioned brains from FKRPKD embryos harvested at E15.5 revealed extensive 
defects in cortical lamination, with substantial glioneuronal heterotopia present in all of the embryos 
 examined (Figure 1).  Fusion of the interhemispheric fissure and hydrocephalus, reported in FKRPKD 
mice at P0 [37], were not present at this time point, indicating that these lesions develop later in foetal 
development. Interestingly, in some areas (particularly the pyriform cortex), disruption appeared 
more extensive than at P0 suggesting there may be some degree of compensation occurring during 
the later stages of brain development (Figure 6A-H). 
 
As observed at E10.5 and E12.5, the pial basement membrane in FKRPKD mice at E15.5 was not 
identifiable with laminin, IIH6 or beta dystroglycan immunolabelling. Laminin immunolabelling 
revealed that the subarachnoid vessels, which are superficial to the pia mater in the subarachnoid 
space at the surface of the brain in wild type mice, were partially to totally surrounded by ectopic 
neurons in FKRPKD embryos (Figure 6I,J). Immunolabelling for the IIH6 epitope of glycosylated alpha 
dystroglycan delineated the pial basement membrane in wild type embryos but labelling was absent 
in FKRPKD mice (Figure 6K, L). Beta dystroglycan labelled the blood vessels, the pia and the arachnoid 
of wild type mice, however in FKRPKD mice, whilst there was some staining of cell bodies in the 
ventricular zone, of the arachnoid mater and subarachnoid vessels; the pia was not apparent (Figure 
6M, N).  Levels of staining for beta dystroglycan in the FKRPKD were however, similar to those observed 
in wild type embryos (Figure 6M, N). BLBP immunolabelling at E15.5 consistently labelled the radial 
glial cell bodies within the subventricular zone at all levels of the developing CNS. In addition to this, 
in wild type animals, there was a narrow (approximately 1µm), continuous immunopositive layer, 
apparent at the peripheral margin of the cortex, consistent with the glia limitans. The glia limitans was 
not identifiable in FKRPKD mice, although scattered immunopositive foci (representing detached radial 
glial end feet) were present within the disorganised cortical plate and extra cortical layer (Figure 6O,P). 
 
Cajal-Retzius cells are mislocalised and are morphologically abnormal in FKRPKD mice 
 
We have previously demonstrated a statistically-significant decrease in the number of Cajal-Retzius 
cells in the rostral cortex of FKRPKD mice at P0, with a concurrent increase in numbers at the level of 
the  hippocampus  at  this  time  point  [37].  Here,  investigation  of  Cajal-Retzius  cells  at  earlier 
 developmental time points, revealed mislocalisation at E12.5 (Figure 7A, B) and E15.5 (Figure 7C, D). 
At E12.5, in wild type animals, the Cajal-Retzius cells formed a monolayer in the superficial preplate 
(preplate splitting).   In the FKRPKD, clusters of reelin-positive cells were located in the caudal 
neocortex, in the region of the cortical hem and the developing hippocampal formation. By E15.5 
Cajal-Retzius cells in FKRPKD mice, rather than forming a discrete layer below the pial basement 
membrane, were instead surrounded by heterotopic neurons (Figure 7C, D). In agreement with these 
observations, quantitative analyses showed that in the rostral cortex, numbers of Cajal-Retzius cells 
in FKRPKD mice were significantly decreased (Figure 7E). 
 
Cell signalling during brain development in FKRPKD mice 
 
 
There is no discernable perturbation of the reelin signalling pathway in FKRPKD mice at P0 
 
In view of the observed mislocalisation of Cajal-Retzius cells we next sought to determine if signalling 
pathways downstream of reelin had been disrupted. Disabled-1 (Dab1) is a phosphoprotein, which 
serves as a reelin signal transducer [39] and complexes with the intracytoplasmic domains of the 
lipoprotein receptors VLDL and ApoER2, and with the intracytoplasmic domain of α3β1 integrin. 
Reelin binding to one of these receptors leads to phosphorylation of Dab1, binding of Lis1 and 
activation of non-receptor tyrosine kinases. In addition, phosphorylated Dab1 becomes 
polyubiquitinated, targeting it for degradation by the proteasome.  This serves as a feedback loop, 
providing the “stop” signal which prevents neuronal overmigration. Reeler mice have been 
demonstrated to accumulate non-phosphorylated Dab1 in the cortex [39]. 
 
Western blot analyses showed Dab1 expression to be similar in both wild type and FKRPKD mice at P0 
(Figure 8A).  No difference was observed in Dab1 expression in mutant and wild type mice at E15.5 
(data not shown).  Lis1, also known as platelet-activating factor acetylhydrolase IB subunit alpha 
(PAFAH1B) is a protein which binds to dynein, regulating microtubule reorganisation within cells. Lis1 
is known to be mutated in cases of classical lissencephaly and is downstream in the reelin signalling 
 pathway [40]. However, Western blot analysis of brain lysates at P0 showed no difference in the 
amount of Lis1 protein in the brains of FKRPKD mice relative to wild type at P0 (Figure 8B). 
 
There are no downstream changes evident in the phosphatidylinositol 3-kinase (PI3K) signalling pathway 
The PI3K/Akt pathway is common intracellular signalling pathway which is downstream of a number 
of non-receptor tyrosine kinases, G-protein-coupled receptors, B and T cell receptors and others, 
including lipoprotein and integrin receptors.  It is a common downstream component of both β1 
integrin and reelin signalling pathways. Stimulation of these leads to production of 
phosphatidylinositol 3, 4, 5 triphosphates by PI3K, which in turn activate Akt.  Activation of this 
pathway has a diverse range of effects on processes such as cell proliferation and survival (particularly 
apoptosis), protein synthesis and glucose synthesis. Given the changes observed in reelin expression 
immunohistochemically, and Lis1 by western blot, we therefore sought to determine if there were any 
downstream effects on Akt activity. Western blots revealed that expression of Akt was similar in wild 
type and FKRPKD mice at P0, as were the levels of phosphoAkt (Figure 8A, B).   Semi quantitative 
analyses of these blots is shown in Figure 8C where levels were normalised against beta dystroglycan. 
 
Discussion 
 
 
Four key events have been previously implicated in the development of cobblestone lissencephaly – 
neuroglial ectopia (caused by neuronal overmigration), Cajal-Retzius cell mislocalisation, and 
disruption to the pial basement membrane, with abnormal anchorage of radial glial cells. These factors 
are considered to be interrelated, but the precise mechanisms underlying their development are 
unknown. 
 
Dystroglycan is widely expressed and has been attributed with a key role in basement membrane 
deposition/assembly [41].  The current work shows that that lesions in the basement membrane 
initially arise between E10.5-E11.5 in FKRPKD mice which is consistent with such a role, but is much 
earlier than has been reported in other dystroglycanopathy mouse models. Interestingly the only 
 other mouse model with a cobblestone lissencephaly phenotype currently reported to exhibit brain 
defects as early as the FKRPKD mouse, is a model with a deletion of the nidogen binding site of laminin 
γ1 [42]. Similar to FKRPKD  mice, this model exhibited breakdown of the basement membrane from 
E10.5 and failure of migration of the Cajal-Retzius cells [42]. 
 
In Pomgnt1-/- mice, Pomt2f/f;Emx1-Cre+ mice and Nestin cre-DG null mice, basement membrane defects 
and neuroglial ectopia were first observed at E13.5 [38, 43, 44]. E13.5 is a time point at which the 
developing cortex begins to undergo rapid expansion by the radial migration of post-mitotic neurons. 
The identification of lesions at this time point therefore led authors to conclude that defects in the 
ability of radial glial cells to appropriately organise/stabilise the basement membrane during this 
period of rapid cortical expansion underpinned the neuronal migration defects in these models [32, 
44]. Some of the discrepancies with our observations of early defects at E10.5 may however, relate to 
 
the precise time point at which expression of either dystroglycan or its glycosylation was 
removed/altered in this work. In the case of the Pomt2f/f;Emx1-Cre+, whilst Pomt2 expression was 
knocked-out from approximately E9.5, this was limited to the neural progenitor cells [43].  In Nestin 
cre-DG null mice, expression of dystroglycan was removed from E10.5, and glycosylated alpha 
dystroglycan (evident as IIH6 immunoreactivity) present until E12.5 [44].  The mutation in the FKRPKD 
mouse used in this study is consitituitve. As radial glial cells do not differentiate until around E12.5 in 
the mouse [45], our observations at E10.5 suggest the involvement of other cellular events and a more 
complex pathogenesis than originally appreciated in the dystroglycanopathies. 
 
Cajal-Retzius cells migrate between E10.5-E11.5, coinciding with the time point at which brain lesions 
are first apparent in FKRPKD mice. Indeed, we observed that Cajal-Retzius cells fail to migrate normally 
in FKRPKD mice, and showed that there are significant decreases in the number of Cajal-Retzius cells in 
the rostral cortex of FKRPKD mice at E15.5, when compared to wild type controls. 
 
The decrease in the number of Cajal-Retzius cells in the rostral cortex at E15.5, indicated by counts of 
reelin-positive cells, suggests either a failure of migration of Cajal-Retzius cells or a decrease in the 
 number of these cells.  We have previously identified an increase in the number of Cajal-Retzius cells 
in neonatal FKRPKD mice at the level of the hippocampus – a structure which develops from the cortical 
hem (a birth place of Cajal-Retzius cells) [37]. However, Cajal-Retzius cells are a heterogeneous group 
of cells, with different sites of origin, gene expression patterns and migratory routes [46-48].  The 
rostral and lateral cortex of mice are populated by Cajal-Retzius cells which originate from the medial 
septum and the ventral pallium [46, 47]. These data together with that previously reported therefore 
suggests that a knock down in Fkrp specifically affects the subpopulations of Cajal-Retzius cells 
originating from the medial septum and ventral pallium, whereas those originating from the cortical 
hem are relatively spared. 
 
Mislocalisation of Cajal-Retzius cells in mouse models of the dystroglycanopathies (including 
Pomgnt1-/- mice and Nestin cre/DG-null mice) has been identified by others, although the pattern of 
mislocalisation in these models was not suggestive of failure of migration from their site of origin [32, 
38].   Failure of Cajal-Retzius cell migration has been previously reported in mouse models with 
 
cobblestone lissencephaly phenotypes not associated with the hypoglycosylation of alpha 
dystroglycan, namely mice deficient in β2 and γ3 laminins, and those with a deletion of the nidogen 
binding site of laminin γ1 [42, 49].  These observations together with our data suggest that the 
migratory route of this cell population is dependent on early basement membrane formation. 
Whether this dependence is mediated via secreted cues or through direct interaction is not clear at 
the present time. 
 
Neuroepithelial cells are the precursors of the radial glial cell population. Considering the role of radial 
glial cells in basement membrane maintenance at later gestational time points [32], and the relatively 
high expression of the IIH6 epitope of alpha dystroglycan by neuroepithelial cells in wild type mice at 
early developmental stages, it might be suggested that our observations relate to defects in the 
neuroepithelial cells. However, Cajal-Retzius cell migration has previously been shown to be 
independent of the neuroepithelium, and instead dependent on the integrity of the leptomeninges 
 [33].   The role of the leptomeninges in Cajal-Retzius cell migration, and the disruption to the 
leptomeninges we have previously reported in FKRPKD mice at P0, focuses attention on a potential role 
for these cells in the pathogenesis of the brain phenotype in FKRPKD mice [37]. 
 
In spite of a significant decrease in the number of Cajal-Retzius cells in the rostral cortex of FKRPKD 
mice at P0, no global changes were observed in Lis1, Dab1 or Akt (Figure 8) which are all components 
of the reelin signalling pathway [50]. Mutations in LIS1 and RELN, which result in a decrease or loss of 
expression of these proteins, have previously been identified as causes of classical (type I) 
lissencephaly [51, 52], but expression of Lis1 has not previously been investigated in the cobblestone 
lissencephalies. Our data shows the cell autonomous nature of this signalling pathway and moreover, 
indicates that an early event in the disease process is due to mislocalisation of reelin rather than an 
alteration in downstream signalling processes. Interestingly beta dystroglycan showed a small 
reduction in the FKRPKD relative to wild type. As to whether this is a secondary consequence of 
basement membrane disruption or reflects a down regulation of the Dag1 gene is unclear at the 
present time. 
 
Conclusions 
 
 
In summary, our work shows that basement membrane defects predate radial glial cell differentiation 
and occur around the time of Cajal-Retzius cell migration.  In agreement with this Cajal-Retzius cells 
are mislocalised from early in brain development, however, this was not associated with any apparent 
disruption in the reelin, and downstream PI3K/Akt signalling pathways. 
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 Figure legends. 
 
Figure 1: Incidence of brain lesions in FKRPKD mice 
 
A. Incidence of brain lesions in FKRPKD embryos. Evidence of a neuronal migration defect, manifest as 
neuroglial heterotopia, was apparent in 60% of all FKRPKD embryos at E10.5.  At later developmental 
time points, these lesions were identified in 100% of FKRPKD embryos. B – E. Semi-quantitative ranking 
of the severity of lesions in FKRPKD  embryos. Lesions were initially subtle and focal in nature, but 
through development became much more substantial and were multifocal to coalescing. There was 
some variation in the severity of brain lesions in FKRPKD mice from E11.5 onwards. Lesion severity was 
ranked as follows:  0 = normal, 1 = minimal.  Focal defect in the pial basement membrane, with 
herniation of cells through the defects, 2 = mild. Multifocal defects in the PBM, herniation of cells 
through defects. 3 = moderate. Moderate disorganisation of the developing cortex, limited or 
multifocal organisation of the cortical plate. 4 = marked. Significant disruption to the developing 
cortex, no differentiation of the areas of organisation. 5 = massive.  Complete disorganisation of the 
developing cortex, no normal structures apparent. 
 
 
 
 
 
 
 Figure 2: Early brain development in FKRPKD mice 
 
A, B. Subtle lesions, characterised by multifocal disorganisation of the neuroepithelium, are apparent 
in the striatum of the LGE in HE stained sections of 60% of FKRPKD embryos at E10.5 (arrowheads). C, 
D.  Immunolabelling of the IIH6 epitope of glycosylated alpha dystroglycan at E10.5 reveals there is 
strong, diffuse staining of the wild type neuroepithelium at this time point (C). In addition, note the 
strong staining of the adjacent developing oral epithelium. Immunolabelling is not present in the 
FKRPKD (D). E, F. Laminin immunolabelling. In wild type mice, a continuous, laminar, immunopositive 
layer is present along the surface of the neuroepithelium (basement membrane), although the 
neuroepithelium itself does not stain.  There is some staining of the adjacent, as yet undifferentiated 
mesenchyme. In contrast to the neuroepithelium, the oral epithelium is strongly immunopositive.  In 
the FKRPKD  mice at this time point, an immunopositive neuroepithelial basement membrane is not 
apparent. G, H.  By E11.5, brain lesions, characterised by disorganisation of the neuroepithelium and 
clustering of ectopic cells within the surrounding mesenchyme, are obvious in the HE stained sections 
of all FKRPKD mice examined (arrowheads). A, B, G, H – bars represent 100µm; C, D, E, F – bars 
represent 50µm. NE = neuroepithelium; M = mesenchyme; BV = blood vessels; OE = oral epithelium; 
LGE = lateral ganglionic eminence. 
  
 Figure 3: FKRPKD at the preplate stage 
 
A, B. Cortex (cortical hem). The cortex, intermediate zone of the lateral ganglionic eminence and 
thalamus are disrupted in FKRPKD mice at this level (bold arrows).  C, D. The intermediate thalamus, 
temporal cortex and occipital cortex demonstrate disorganisation and cell ectopia in FKRPKD mice (bold 
arrows). E, F. In wild type mice, the developing cortex is organised and the pial basement membrane 
is visible (arrow heads).   Disorganisation of the preplate and cluster of ectopic cells are readily 
apparent in the FKRPKD  at this time point (bold arrows).   HE.   MS = medial septum; LGE = lateral 
ganglionic eminence; C = Cortex; T = thalamus; CH = cortical hem; MGE = medial ganglionic eminence; 
H = hippocampus.   A-D bars represent 200µm E-F bars represent 100µm 
 
 
 
 
 
  
 Figure 4: FKRPKD at the preplate stage 
 
A-D. Laminin immunolabelling.  In wild type mice, a continuous, laminar, immunopositive layer is 
present along the surface of the preplate (basement membrane), similar to that observed at E10.5 
(arrowheads).   Laminin staining is visible within the developing brain in areas which ultimately 
differentiate into the choroid plexus and the dorsal thalamus.  Basement membrane staining at the 
surface of the preplate is not apparent in FKRPKD mice, but is retained at the choroid plexus and the 
dorsal thalamus.  E, F.  Immunolabelling for the IIH6 epitope of glycosylated alpha dystroglycan.  A 
continuous, laminar immunopositive layer is present along the surface of the preplate (basement 
membrane) in wild type embryos (arrowheads).  In addition, there is intense staining of cell bodies 
and processes, particularly in the thalamus and at the cortical hem (star).  Immunolabelling is not 
present in developing brains of the FKRPKD embryos.  C = Cortex; MS = medial septum; LGE = lateral 
ganglionic eminence; T = thalamus; CH = cortical hem; MGE = medial ganglionic eminence. A, B, E, F – 
bars represent 100µm. C,D – bars present 50µm. 
 
 
 
  
 Figure 5: FKRPKD at the preplate stage 
 
A-D. Beta dystroglycan immunolabelling. Immunostaining in wild type and FKRPKD embryos is similar, 
with beta dystroglycan expression at the basement membrane of the preplate (arrowheads) and the 
choroid plexus, in addition to being present in cell bodies in the ventricular zone and extending along 
cell processes.   In FKRPKD embryos, there are defects in the laminar staining of the basement 
membrane of the preplate, most obviously in the thalamus (*), shown at the higher magnification in 
(D), but also extensively in lateral aspects of the cortex and the LGE.  E-H.  BLBP immunolabelling. 
There is immunolabelling of cell bodies in the ventricular zone, along with the glia limitans and some 
cell processes in the thalamus. In the cortex, the glia limitans does not stain diffusely with BLBP at this 
time point in either wild type of FKRPKD embryos, suggesting that this is the developmental point at 
which differentiation from neuroepithelial cells to radial glial cells is beginning. LGE = lateral ganglionic 
eminence; T = thalamus; CH = cortical hem. A-F bars represent 200µm. G, H bars represent 50µm. 
 
 
 
  
 Figure 6: FKRPKD brain during rapid cortical expansion 
 
A-D The cortical hemispheres remain distinct in the FKRPKD at this time point, although laminar 
organisation is largely absent, and both the cortical plate and the marginal zone are inapparent. The 
cortical surface has a marked, irregular appearance, which extends laterally (B,D see arrows). 
Ventrally and caudolaterally, the striatum and pyriform lobes appear decreased in size when 
compared to wild type mice at this time point. E, F. The FKRPKD exhibits disorganisation of the inferior 
colliculus.  I, J.  A higher magnification view of the neocortex in wild type and FKRPKD mice.  In FKRPKD 
mice there is marked disruption to the cortical plate (bold arrows) and the marginal zone is inapparent. 
Normally superficial blood vessels are multifocally surrounded by ectopic cells. HE. A - F bars represent 
400µm; G, H bars represent 100µm. I, J.  Laminin.  Immunolabelling reveals marked disruption to the 
pial basement membrane in FKRPKD mice.  The subarachnoid vessels, normally apparent superficial to 
the pia at the surface of the brain are partially to totally surrounded by ectopic neurons. Arrowhead 
indicated normal staining of the basement membrane in wild type mice. Inserts show the presence 
and altered distribution of laminin in the wild type and FKRPKD respectively. K, L.  Immunolabelling for 
the IIH6 epitope of glycosylated alpha dystroglycan. Pial basement membranes (arrowhead) are 
strongly immunopositive in wild type mice.  Staining is not present in the FKRPKD mice.  M, N.  Beta 
dystroglycan.  Blood vessels, the pia (arrowhead) and the arachnoid (fine arrow) are 
immunopositive in wild type mice. There is some staining of cell bodies in the ventricular zone. In 
the FKRPKD, immunolabelling of arachnoid and subarachnoid vessels (surrounded by ectopic neurons) 
are still apparent, but the pia is not observed. Inserts show higher magnification of the cortical 
surface . O, P.  BLBP.  In addition to staining at the ventricular zone, there is continuous, laminar 
staining of the glia limitans in wild type mice (bold arrow).  Scattered BLBP-positive foci are 
present in the FKRPKD (bold arrow). M = motor cortex; I = insular cortex; P = pyriform lobe; H = 
hippocampus; LGE = lateral ganglionic eminence; Cb = cerebellum; SC = superior colliculus; MZ = 
marginal zone; CP = cortical plate; SP = subplate; IZ = intermediate zone; VZ = ventricular zone. 
 
 
  
 Figure 7: Localisation of Cajal-Retzius cells through brain development 
Immunohistochemical staining with antibodies to reelin. Cajal-Retzius cells are mislocalised early in 
brain development and prior to the differentiation of radial glial cells.  A, B.  At E12.5, in the FKRPKD, 
Cajal-Retzius cells are mislocalised, often clustered in the mesenchyme surrounding the developing 
brain.  C, D.  By E15.5, in the dorsolateral cortex of FKRPKD mice, numbers of Cajal-Retzius cells (bold 
arrows) appear dramatically reduced. Rather than forming a discrete layer below the pial basement 
membrane (arrowheads) within  the  marginal  zone  as  in  wild  type  mice, Cajal-Retzius  cells  are  
surrounded by heterotopic neurons.  E.  In the rostral cortex at E15.5, there was a statistically 
significant decrease in the number of Cajal-Retzius cells in FKRPKD mice when compared with wild type 
controls (unpaired t test with Welch’s correction, P = 0.0053).  A – D bars represent 100µm. 
 
 
  
 Figure 8: Reelin signalling in the brain at P0 
 
An analysis of whole brain extracts at P0 from wild type and FKRPKD (mutant) mice. A. DAB1 and Akt, 
B. phospho Akt, Lis1 and beta dystroglycan C. a semi quantitative assessment of levels using 
densitometry. All levels were normalised to the loading control (beta dystroglycan) and indicate no 
statistically significant differences (two sample t-test) between wild type and FKRPKD with respect to 
either DAB1, Akt, phospho Akt or Lis 1. Error bars represent standard error of the mean. No alteration 
in the mobility of beta dystroglycan is evident in the FKRPKD compared to wild type. 
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